BCI@Home: Brain Computer Interface Solutions to Enable Youth Living With Severe Disabilities
Launched by UNIVERSITY OF CALGARY · Jul 17, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of technology called a brain-computer interface (BCI) that could help children with severe physical disabilities, like cerebral palsy or brain injuries, participate more fully in daily life. The researchers want to see if using this technology at home can help kids reach personal goals that matter to them and also how well this program can be used in real-life home settings.
Children between 5 and 18 years old who have very limited movement—such as not being able to walk or use their hands much—and/or have trouble communicating may be eligible. Participants need to be able to understand and follow simple instructions, and their home needs to be a good fit for using the BCI, as decided by healthcare providers and families. If accepted, families will work with the research team to use the BCI program at home and track how it helps with the child’s daily activities. It’s important to note that children with certain types of epilepsy or brain conditions that don’t work well with the BCI won’t be able to join. This study is not yet open for enrollment but aims to make this helpful technology more accessible for kids living with severe disabilities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 5-18 years
- • Severe motor impairment including inability to walk and minimal functional hand use, and/or;
- • Severe communication impairment
- • Ability to follow simple instructions and attend to simple tasks
- • Home environment suitable for the program based on clinician and family discussion;
- • Informed assent/consent
- Exclusion Criteria:
- • Epileptic encephalopathy
- • Unstable epilepsy, or
- • Brain imaging incompatible with BCI functionality
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported